Author:
Onal Mehmet Bulent,Bilginer Burcak,Narin Firat,Ziyal M. İbrahim,Soylemezoglu Figen,Ozgen Tuncalp
Reference31 articles.
1. Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases.Neurosurgery 2001;48(4):723–8; discussion 728–730.
2. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. Am J Neuroradiol. 2004;25(5):819–826.
3. Belen D, Besalti O, Yiğitkanli K, Kösemehmetoğlu K, Simşek S, Bolay H. Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage. Acta Neurochir (Wien). 2007;149(10):1041–7; discussion 1047–1048.
4. Bilginer B, Onal MB, Yigitkanli K, Soylemezoglu F, Bavbek M, Ziyal IM, et al. Treatment of cerebral vasospasm with cilostazol in subarachnoid hemorrhage model. Acta Neurochir Suppl. 2008;104:291–295.
5. Birk S, Kruuse C, Petersen KA, Jonassen O, Tfelt-Hansen P, Olesen J. The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J Cereb Blood Flow Metab. 2004;24(12):1352–1358.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献